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Abstract
Introduction A small proportion of individuals with non-
specific low back pain (NSLBP) develop persistent prob-
lems. Up to 80% of the total costs for NSLBP are owing to
chronic NSLBP. Psychosocial factors have been described
to be important in the transition from acute to chronic
NSLBP. Guidelines recommend the use of the Acute Low
Back Pain Screening Questionnaire (ALBPSQ) and the
O¨rebro Musculoskeletal Pain Screening Questionnaire
(O¨MPSQ) to identify individuals at risk of developing
persistent problems, such as long-term absence of work,
persistent restriction in function or persistent pain. These
instruments can be used with a cutoff value, where patients
with values above the threshold are further assessed with a
more comprehensive examination.
Methods We systematically reviewed studies evaluating
the accuracy of the ALBPSQ and O¨MPSQ to predict per-
sistent problems.
Results The 13 included studies used different cutoff
values for the screening questionnaires ranging from 68 to
147. The pooled sensitivity was 0.59 (0.43–0.74), while the
pooled specificity was 0.77 (0.66–0.86). Heterogeneity (I2)
was 90.02% for sensitivity and 95.41% for specificity.
Conclusion Thus, we do not recommend the use of one
cutoff value, but the use of a prediction model with all the
individual items.
Keywords Back pain  Prognosis  Screening 
Psychosocial
Introduction
Patients with musculoskeletal problems generate enormous
economic loss to society [1] due to both absenteeism and
reduced productivity (presenteeism) [2]. The majority of
these costs are caused by a small proportion of patients
with musculoskeletal problems developing persisting
restriction in participation (e.g., work and other role ful-
fillments). Multimodal assessment and rehabilitation,
which is recommended for patients at high risk for devel-
oping persistent problems, is expensive [3]. Therefore,
these expensive assessments and interventions should only
be allocated to those with a substantial risk. Early detection
of these patients could improve the process of treatment
allocation, optimize the cost-benefit ratio, and reduce the
burden of disease for society, as well as the individual
patient. Several guidelines for the management of back
pain or other musculoskeletal pain conditions recommend
the assessment of red flags at the first visit, and yellow flags
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if a patient does not improve after 2–8 weeks after the
onset of a new back pain episode (see Koes et al. [4] for an
overview). Red flags are warning signs for serious diseases,
such as cancer, fracture, inflammation, or progressive
impairment of neurological function. Yellow flags indicate
psychosocial factors suspected to be involved in the tran-
sition to chronic pain and restrictions in activity and par-
ticipation [5, 6]. If no red flags are identified, the
assessment of psychosocial factors should help us to (1)
target the interventions and (2) support the decision of
whether a multimodal, and thus expensive, rehabilitation
should be envisaged, or whether monomodal treatment is
sufficient [3]. One instrument that was built to integrate
different biopsychosocial aspects into one questionnaire
and one summary score is the Acute Low Back Pain
Screening Questionnaire (ALBPSQ) [7]. This question-
naire is recommended by guidelines from New Zealand
and Australia to identify individuals at risk of developing
chronic non-specific low back pain (NSLBP) [8, 9]. The
ALBPSQ was first published by Linton and Hallden [7],
comprising different items from existing questionnaires.
The O¨rebro Musculoskeletal Pain Screening Questionnaire
(O¨MPSQ) is an adaptation of the ALBPSQ: one question is
formulated differently, such that all musculoskeletal pain is
addressed, instead of only back pain [10]. The ALBPSQ
and O¨MPSQ each have 25 items, covering days off work,
anxiety and tension, depression, pain, activities of daily
living related to pain, coping, job satisfaction, fear-avoid-
ance beliefs, and patient’s expectations to recover. These
items provide information about possible psychosocial
problems, helping the interdisciplinary teams to discuss
such problems with the patient and consider tailored
interventions. A total score is calculated from 21 items and
can range from 2 to 210 points. Higher values indicate
more psychosocial problems. A cutoff value of 105 has
been proposed for indicating those ‘‘at risk’’ for developing
persistent problems [10, 11].
There are mainly two approaches for prediction [12]. In
the predictive model approach, the risk of a given outcome
is estimated by the means of appropriate regression models
(e.g., logistic or cox regression). This method provides an
estimated risk (e.g., a risk of 0.8 for persisting pain at
6 months means that among 100 similar patients, 80 would
still have persisting pain at 6 months). However, a decision
on treatment (e.g., usual care vs. expensive multimodal
treatments) has to be made on a yes/no basis. The decision is
relatively easy for patients with a very low or a very high
risk, but it is more difficult for those with an intermediate
risk. Therefore, some clinicians prefer the second approach,
where the predictive value of risk factors are presented as
true positive fraction (sensitivity) or true negative fraction
(specificity). Both the capabilities (detection of patients
who will and those who will not develop the given outcome)
can be summarized with a receiver operating characteristic
curve (ROC curve).
Only few prognostic tests have both a high sensitivity and
high specificity [13]; for most, there is a tradeoff between the
two statistics. In the case of the ALBPSQ, lowering the cutoff
would decrease the proportion of false negatives, but
increase the proportion of false positives. Whether a pre-
dictive instrument should have a high sensitivity or a high
specificity depends on its use: a high sensitivity (and thus a
low specificity) will lead to a high proportion of patients
referred to a multimodal, and thus expensive, rehabilitation,
and due to the low specificity, not all of them need this
expensive intervention (i.e., might get better without a
multimodal intervention). On the other hand, a high speci-
ficity and thus a relatively lower sensitivity would lead to a
high proportion of patients failing to receive multimodal
rehabilitation. Therefore, clinicians and case managers have
to carefully decide about the cutoff value. In the case of the
ALBPSQ and O¨MPSQ, a high cutoff value could lead to high
specificity and low sensitivity, while a low cutoff value could
lead to high sensitivity and low specificity.
Most often, the ALBPSQ and O¨MPSQ will be used in a
triage setting, where patients with a positive test result will
then be assessed with tests that are more complex, such as a
psychological assessment. Therefore, we presume that a
high sensitivity would be preferable in the triage setting.
Hockings et al. [14] published a systematic review of the
predictive value of the ALBPSQ and O¨MPSQ. However, no
statistical pooling was performed and since then several
new relevant articles have been published. With this diag-
nostic meta-analysis, we set out to evaluate how accurate
the ALBPSQ and O¨MPSQ could predict the persistent
problems, such as sick leave, pain, or decreased function in
patients with NSLBP or musculoskeletal problems.
Methods
Identification of studies
We included prospective studies that used either the AL-
BPSQ or O¨MPSQ, and reported the predictive values for
pain, work status, sick days, or function at follow-up in
patients with musculoskeletal pain (back pain, shoulder pain,
etc.). We searched PubMed, Embase, and Web of Science
from 1998 (first publication of the ALBPSQ) to March 2010,
and considered only articles in the English language. The
search string is available on request. It focused on back pain,
musculoskeletal pain, and the ALBPSQ or O¨MPSQ. In
addition, we entered the original studies of the two ques-
tionnaires [7, 10] into the Science Citation Index Database
(Web of Science, Thomson ISI, Philadelphia, PA, USA) and
Google Scholar to identify citing studies.
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Selection criteria
Two reviewers independently screened the abstracts and
titles retrieved by the electronic searches. Two reviewers,
using a checklist to assess the inclusion criteria, reviewed
the full texts of 46 articles. Prospective studies were
included if one of the two questionnaires was assessed in
patients with back pain or musculoskeletal pain (of any
duration) and if follow-up data were available for recovery
(pain, function, work status, etc.), to construct a 2 9 2
table to calculate the sensitivity and specificity; i.e., true
negative, false negative, true positive, and false positive
values were available. Disagreement about inclusion was
resolved by consensus or by a third reviewer.
Methodological quality assessment
We used the criteria proposed by Hayden [15] to assess the
study quality and its risk of bias: study participation, study
attrition, prognostic factor measurement and outcome
measurement, and confounding measurement and account.
Data extraction
Two reviewers independently extracted the data of the
studies. Inconsistencies were resolved by discussion
between both the reviewers.
For the description of the study, we extracted the setting,
patient recruitment, time point of assessment (relative to
the course of the pain problem), time point of follow-up
assessment, whether or not patients were enrolled consec-
utively, number of patients eligible, number of patients
included at baseline, number of patients assessed at follow-
up, description of pain duration and location, and definition
and assessment of outcomes.
Statistical analysis
True positives, false positives, true negatives, and false
negatives were calculated for different cutoff values, if
possible. If data were not available to calculate these val-
ues, the authors were contacted with the question to pro-
vide values for sensitivity and specificity for at least two
cutoff values, if possible for the most consistently reported
cutoff values (i.e., 105).
Meta-analysis
We pooled sensitivity and specificity with a bivariate
diagnostic meta-analysis (metandi: user written commands
in STATA) [16, 17]. This method fits a two-level model,
with independent binomial distributions for the true posi-
tives and true negatives, conditional on the sensitivity and
specificity in each study, and a bivariate normal model for
the logit transforms of sensitivity and specificity between
the studies [18].
We used a general linear mixed model approach for
bivariate meta-analysis.
As different studies presented different thresholds (cut-
off values), we plotted a summary ROC curve. A 95%
confidence ellipse (bivariate model) and a 95% prediction
ellipse (where we would expect that 95% of future studies
will lie) within the ROC space were calculated. Each data
point in the summary ROC represented a separate study.
If one study reported on more than one outcome, we
chose, if possible, a work-related outcome. If one study
reported on more than one follow-up time points, we
selected only the longest follow-up period.
Heterogeneity
Statistical heterogeneity was assessed with the I2 statistic
of the pooled sensitivities and specificities. As a rule of
thumb, 25% or less may be considered as low heteroge-
neity, 50% as moderate, and 75% as high heterogeneity
[19].
Due to the low number of studies, a meta-regression to
evaluate the potential variables explaining heterogeneity
was not possible. The possible factors explaining the het-
erogeneity could have been: (1) pathology, (2) baseline
prevalence of patients at risk (spectrum), (3) kind of out-
come, and (4) time point of follow-up.
Results
The search in the electronic databases identified 46
potential eligible studies. From these, 14 studies [7, 10, 20–
31] met our inclusion criteria, reporting on 16 samples. Six
studies evaluated the accuracy to predict the persistent
problems with the ALBPSQ [7, 22–25, 30], while eight
studies and ten samples reported on the O¨MPSQ [10, 20,
21, 26–29, 31]. Table 1 shows the characteristics of the
included studies. The size of the study population ranged
between 89 [29] and 328 [22] participants. Seven studies
focused not only on patients with low back pain [10, 20, 21,
27, 29–31], but also on those with other problems as well.
Most studies assessed patients within 12 weeks after the
onset of a pain episode. One study had 85% of patients with
longer pain duration [31]. The outcome measurements
were heterogeneous and included the following: non-return
to work [20, 25, 29], decreased sick leave level [31], sick
days [7, 10, 21–23, 27, 30], recovery assessed with two
questions of overall recovery [24], and Roland–Morris
Questionnaire [28],
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Risk of bias of the included studies
For the categories of study participation, study attrition,
prognostic factor measurement, and outcome measurement,
we considered the risk of bias to be minimal. For the
confounding measurement and account, there may be a
moderate risk of bias due to uncontrolled factors, such as
treatment. For the criterion ‘‘analysis,’’ we could calculate
true positives, true negatives, false positives, and false
negative for all studies, except for the study by Westman
et al. [31], where we estimated the content of the four cells
with the reported sensitivity, specificity, and number of
patients.
Overall results
The pooled summary sensitivity was 0.59 (0.43–0.74),
implying that 59% of the patients developing persistent
problems would be correctly classified as ‘‘at risk’’ when the
ALBPSQ or O¨MPSQ was applied, whereas the pooled
specificity was 0.77 (0.66–0.86), implying that 77% of the
patients not developing persistent problems would be
classified as ‘‘at no risk.’’ Heterogeneity for sensitivity and
specificity was (I2) 90.02% (95% CI 86.24–93.79) and
95.41% (95% CI 94.03–96.78), respectively (see Figs. 1, 2).
Discussion
With this systematic review and meta-analysis, we found
that the prediction with the ALBPSQ or O¨MPSQ has too
much heterogeneity to recommend the use of a definite
cutoff value (e.g., 105). Due to this high heterogeneity, the
pooled sensitivity and specificity should be regarded with
care. Overall, the two questionnaires would appear to have
only weak to moderate predictive value for the develop-
ment of persistent problems.
This is the first attempt to statistically summarize the
predictive value of two widely used questionnaires for the
prediction of persistent musculoskeletal pain.
There are several limitations inherent to our meta-
analysis: we pooled the different outcomes, being aware of
different problems with this approach because: (1) the
effect sizes vary between the different outcomes and the
Q =150.24, df = 15.00, p =  0.00
I2 = 90.02 [86.24 - 93.79]
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0.79 [0.62 - 0.91]
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COMBINED
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SENSITIVITY
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2007 LBP Not recovered 104
Hurley 2001 LBP Work loss 112
Linton 1998 BP >30 sick days 105
Westman 2008 MSKP Sick leave 117
Dunstan 2005 MSKP NRTW 105
Linton 2010 BP >14 sick days 101
Linton 2003 BP >30 sick days 105
Linton 2010 BP >14 sick days 101
Vos 2009 NP >7 sick days 80
Gabel 2011 BP >28 sick days 120
Grotle 2006 BP >30 sick days 105
Maher 2009 BP RM>4 105
Margison 2007 BP NRTW 147
Jellema 2007 BP Not recovered 105
Grimmer 2008 BP > 90 sick days 105
Margison 2007 MSKP NRTW 147
Fig. 1 Forest plot: ALBPSQ or O¨MPSQ with different outcomes.TP true positive, FP false positive, FN false negative, TN true negative, LBP
low back pain, BP back pain, MSKP musculoskeletal pain, NP neck pain, NRTW non-return to work, RM Roland–Morris Questionnaire
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statistical summary of these data may lead to a biased
summary estimate [32], (2) different outcomes most
probably have different predictors; e.g., work loss most
likely has a different predictor than function, and (3)
interpretation of the summary statistics is difficult when
different outcomes are pooled. Nevertheless, as a separate
analysis of the different outcome was not possible because
of the low number of studies for each outcome, we presume
that pooling of the different outcomes is the best approach
to summarize the overall predictive value of the two
questionnaires.
Furthermore, from the results of this study, it is not
possible to define the best threshold (cutoff value). The
high heterogeneity limits the information of the summary
values for sensitivity and specificity, as the clinician cannot
estimate the influence of a given setting on sensitivity and
specificity at the recommended threshold of 105.
Reasons for heterogeneity might be as follows: (1)
predictive values differ between patients with back pain or
those with other pain sources, as shown, e.g., in the study
by Margison et al. [29], and most of the studies had a
different case-mix. (2) Outcomes were different, and even
the work-related outcomes were assessed differently in
different studies. (3) Time points of follow-up assessments
differed among the studies. Although sensitivity and
specificity are not inherently influenced by the prevalence
of the outcomes, it has been demonstrated that the patient
spectrum clearly influences the sensitivity and specificity
[33]. (4) Treatment may successfully address predictive
factors and thus make the ‘‘static’’ predictive model less
predictive (to adjust for this, one could assess the predictors
several times during a follow-up period and adjust the
predictive model). (5) The examined studies were rather
small with few cases, which can lead to different sensi-
tivities and specificities due to sample variability (i.e., by
chance).
Several published and ongoing studies have used one of
the two questionnaires in conjunction with other (potential)
predictors. Further systematic reviews will indicate whe-
ther these combinations improve the predictive value.
In the case of the ALBPSQ and O¨MPSQ, dichotomizing
the prediction (good/bad outcome) will lead either to a high
sensitivity with a relative lower specificity or to a high
specificity with a relative lower sensitivity, as shown in
Figs. 1 and 2. However, more promising would be to use
the items of the questionnaire as a prediction rule (a
probability calculation with a formula giving a weight to
each question in the questionnaire). One could argue that
case managers or medical doctors need cutoff values to be
able to make a clear and objective decision. However,
probability scores would allow us to integrate further
information, such as the ‘‘gut feeling’’ of the case manager.
Furthermore, one might argue that if the workload is high
and the medical doctor could not assess all patients in
detail, he/she needs to have clear cutoff values to decide on
which patient should be assessed thoroughly. However, a
clear cutoff value could also be based on probability
models; e.g., one could refer to in-depth assessment of all
patients with a risk probability of over 90%. Furthermore,
this cutoff value can be adapted according to resources, i.e.,
can be increased when resources are sparse.
A second solution would be to define two thresholds, a
higher one for high specificity, and a lower one for high
sensitivity. This would allow ruling out the risk for pro-
longed sick leave or function-related problems in a patient
with a value below the lower threshold, while ruling in the
risk in a patient with a value higher than the upper
threshold. For all patients with values between the two
thresholds, no decision can be made and further tests must
be carried out.
Strictly, the use of an overall score only makes sense for
unidimensional scales [34]. This is questionable regarding
the ALBPSQ or O¨MPSQ, as they were constructed with
items from questionnaires covering different constructs
(dimensions). Therefore, the use of sub-scores may
improve prediction. There is some evidence that subscales
have better predictive values; e.g., in [24]: The ALBPSQ
subscales, ‘‘pain’’ and ‘‘function/pain/psychology and fear-
avoidance beliefs,’’ showed better predictive values than
the total score (area under the ROC curve: 0.641 (total
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Fig. 2 Summary ROC plot: ALBPSQ or O¨MPSQ with different
outcomes
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score), 0.855 (function/pain/psychology and fear-avoid-
ance beliefs), and 0.817 (pain)).
Even if we assumed that a summary score for this
questionnaire was sound and decided not to use a proba-
bility model, we would still be unable to make a clear
recommendation on the cutoff value because of the heter-
ogeneity of the cutoff value used in the studies. One
approach to deal with this uncertainty about the cutoff
value might be to build a database including about 100
patients in a given setting and to calculate the optimal
cutoff value for this setting. For example, Margison et al.
[29] decided to use three cutoff values after the evaluation
of their patients:\99 for the classification as ‘‘patient with
mainly biomedical pain generator;’’ 140–147 as ‘‘high risk
for prolonged disability;’’ and [147 as ‘‘very high risk for
prolonged disability.’’
Conclusion
Practitioners should not use thresholds of the summary
score of the ALBPSQ or O¨MPSQ to identify individuals at
risk of developing chronic pain and disability. Instead, they
should pay more attention to high values for specific items
in the scale that highlight an individual’s problems in the
respective domain. We recommend the use of an individual
risk profile, instead of the summary score. Researchers
should integrate the questionnaire into the probability
models with other risk factors and test the models in large
cohort studies.
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